nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—OPRD1—Amitriptyline—migraine	0.126	0.168	CbGbCtD
Oxycodone—OPRK1—Amitriptyline—migraine	0.105	0.141	CbGbCtD
Oxycodone—OPRM1—Amitriptyline—migraine	0.0925	0.124	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Propranolol—migraine	0.0482	0.0647	CbGbCtD
Oxycodone—CYP3A7—Propranolol—migraine	0.0482	0.0647	CbGbCtD
Oxycodone—CYP3A5—Propranolol—migraine	0.0362	0.0485	CbGbCtD
Oxycodone—CYP3A7—Verapamil—migraine	0.0331	0.0444	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Verapamil—migraine	0.0331	0.0444	CbGbCtD
Oxycodone—CYP3A5—Amitriptyline—migraine	0.0313	0.042	CbGbCtD
Oxycodone—CYP3A5—Valproic Acid—migraine	0.0285	0.0383	CbGbCtD
Oxycodone—CYP2D6—Timolol—migraine	0.0249	0.0334	CbGbCtD
Oxycodone—CYP3A5—Verapamil—migraine	0.0248	0.0333	CbGbCtD
Oxycodone—CYP2D6—Propranolol—migraine	0.0222	0.0298	CbGbCtD
Oxycodone—CYP2D6—Amitriptyline—migraine	0.0192	0.0257	CbGbCtD
Oxycodone—CYP2D6—Verapamil—migraine	0.0152	0.0204	CbGbCtD
Oxycodone—CYP3A4—Propranolol—migraine	0.0141	0.0189	CbGbCtD
Oxycodone—CYP3A4—Amitriptyline—migraine	0.0122	0.0164	CbGbCtD
Oxycodone—CYP3A4—Valproic Acid—migraine	0.0111	0.0149	CbGbCtD
Oxycodone—CYP3A4—Topiramate—migraine	0.01	0.0135	CbGbCtD
Oxycodone—CYP3A4—Verapamil—migraine	0.00968	0.013	CbGbCtD
Oxycodone—Naloxone—ESR1—migraine	0.000439	1	CrCbGaD
Oxycodone—OPRD1—GPCR ligand binding—CALCRL—migraine	0.000203	0.0102	CbGpPWpGaD
Oxycodone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000199	0.00993	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000194	0.0097	CbGpPWpGaD
Oxycodone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000185	0.00923	CbGpPWpGaD
Oxycodone—OPRM1—G alpha (i) signalling events—HTR1D—migraine	0.000181	0.00904	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.00018	0.00902	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—RAMP1—migraine	0.000178	0.00892	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—CALCRL—migraine	0.000178	0.00892	CbGpPWpGaD
Oxycodone—Discomfort—Valproic Acid—migraine	0.000174	0.00074	CcSEcCtD
Oxycodone—Sinusitis—Topiramate—migraine	0.000173	0.000737	CcSEcCtD
Oxycodone—Mental disorder—Gabapentin—migraine	0.000172	0.000734	CcSEcCtD
Oxycodone—Dry mouth—Valproic Acid—migraine	0.000172	0.000733	CcSEcCtD
Oxycodone—Malnutrition—Gabapentin—migraine	0.000171	0.00073	CcSEcCtD
Oxycodone—Dizziness—Propranolol—migraine	0.000171	0.000728	CcSEcCtD
Oxycodone—Asthenia—Verapamil—migraine	0.00017	0.000727	CcSEcCtD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.00017	0.00851	CbGpPWpGaD
Oxycodone—Confusional state—Valproic Acid—migraine	0.00017	0.000724	CcSEcCtD
Oxycodone—Flatulence—Gabapentin—migraine	0.000169	0.000719	CcSEcCtD
Oxycodone—Oedema—Valproic Acid—migraine	0.000168	0.000718	CcSEcCtD
Oxycodone—Anaphylactic shock—Valproic Acid—migraine	0.000168	0.000718	CcSEcCtD
Oxycodone—Bradycardia—Topiramate—migraine	0.000168	0.000718	CcSEcCtD
Oxycodone—Pruritus—Verapamil—migraine	0.000168	0.000717	CcSEcCtD
Oxycodone—Tension—Gabapentin—migraine	0.000168	0.000716	CcSEcCtD
Oxycodone—Angioedema—Timolol—migraine	0.000168	0.000716	CcSEcCtD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000168	0.00839	CbGpPWpGaD
Oxycodone—Dysgeusia—Gabapentin—migraine	0.000168	0.000714	CcSEcCtD
Oxycodone—Infection—Valproic Acid—migraine	0.000167	0.000714	CcSEcCtD
Oxycodone—Haemoglobin—Topiramate—migraine	0.000166	0.000709	CcSEcCtD
Oxycodone—OPRD1—Peptide ligand-binding receptors—NPS—migraine	0.000166	0.00831	CbGpPWpGaD
Oxycodone—OPRD1—Peptide ligand-binding receptors—TAC1—migraine	0.000166	0.00831	CbGpPWpGaD
Oxycodone—Nervousness—Gabapentin—migraine	0.000166	0.000709	CcSEcCtD
Oxycodone—Rhinitis—Topiramate—migraine	0.000166	0.000707	CcSEcCtD
Oxycodone—Back pain—Gabapentin—migraine	0.000166	0.000706	CcSEcCtD
Oxycodone—Hepatitis—Topiramate—migraine	0.000165	0.000705	CcSEcCtD
Oxycodone—Haemorrhage—Topiramate—migraine	0.000165	0.000705	CcSEcCtD
Oxycodone—Nervous system disorder—Valproic Acid—migraine	0.000165	0.000704	CcSEcCtD
Oxycodone—Vertigo—Timolol—migraine	0.000165	0.000704	CcSEcCtD
Oxycodone—Syncope—Timolol—migraine	0.000165	0.000703	CcSEcCtD
Oxycodone—Hallucination—Topiramate—migraine	0.000165	0.000702	CcSEcCtD
Oxycodone—Hypoaesthesia—Topiramate—migraine	0.000165	0.000702	CcSEcCtD
Oxycodone—Muscle spasms—Gabapentin—migraine	0.000165	0.000701	CcSEcCtD
Oxycodone—Tachycardia—Valproic Acid—migraine	0.000164	0.000701	CcSEcCtD
Oxycodone—Vomiting—Propranolol—migraine	0.000164	0.0007	CcSEcCtD
Oxycodone—Pharyngitis—Topiramate—migraine	0.000164	0.0007	CcSEcCtD
Oxycodone—Skin disorder—Valproic Acid—migraine	0.000164	0.000698	CcSEcCtD
Oxycodone—Urinary tract disorder—Topiramate—migraine	0.000163	0.000696	CcSEcCtD
Oxycodone—Oedema peripheral—Topiramate—migraine	0.000163	0.000695	CcSEcCtD
Oxycodone—Hyperhidrosis—Valproic Acid—migraine	0.000163	0.000694	CcSEcCtD
Oxycodone—Rash—Propranolol—migraine	0.000163	0.000694	CcSEcCtD
Oxycodone—Dermatitis—Propranolol—migraine	0.000163	0.000694	CcSEcCtD
Oxycodone—Diarrhoea—Verapamil—migraine	0.000163	0.000693	CcSEcCtD
Oxycodone—Connective tissue disorder—Topiramate—migraine	0.000163	0.000693	CcSEcCtD
Oxycodone—Palpitations—Timolol—migraine	0.000162	0.000692	CcSEcCtD
Oxycodone—Urethral disorder—Topiramate—migraine	0.000162	0.000691	CcSEcCtD
Oxycodone—Loss of consciousness—Timolol—migraine	0.000162	0.000689	CcSEcCtD
Oxycodone—Anorexia—Valproic Acid—migraine	0.000161	0.000685	CcSEcCtD
Oxycodone—Cough—Timolol—migraine	0.00016	0.000684	CcSEcCtD
Oxycodone—Tremor—Gabapentin—migraine	0.00016	0.000684	CcSEcCtD
Oxycodone—Visual impairment—Topiramate—migraine	0.000159	0.00068	CcSEcCtD
Oxycodone—Ill-defined disorder—Gabapentin—migraine	0.000159	0.000677	CcSEcCtD
Oxycodone—OPRD1—Peptide ligand-binding receptors—EDNRA—migraine	0.000159	0.00793	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000158	0.00791	CbGpPWpGaD
Oxycodone—Anaemia—Gabapentin—migraine	0.000158	0.000674	CcSEcCtD
Oxycodone—Hypotension—Valproic Acid—migraine	0.000157	0.000671	CcSEcCtD
Oxycodone—Agitation—Gabapentin—migraine	0.000157	0.00067	CcSEcCtD
Oxycodone—Dizziness—Verapamil—migraine	0.000157	0.00067	CcSEcCtD
Oxycodone—Myalgia—Timolol—migraine	0.000156	0.000667	CcSEcCtD
Oxycodone—Chest pain—Timolol—migraine	0.000156	0.000667	CcSEcCtD
Oxycodone—Arthralgia—Timolol—migraine	0.000156	0.000667	CcSEcCtD
Oxycodone—Angioedema—Gabapentin—migraine	0.000156	0.000667	CcSEcCtD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000156	0.0078	CbGpPWpGaD
Oxycodone—Anxiety—Timolol—migraine	0.000156	0.000665	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000155	0.000662	CcSEcCtD
Oxycodone—Discomfort—Timolol—migraine	0.000155	0.000659	CcSEcCtD
Oxycodone—Eye disorder—Topiramate—migraine	0.000155	0.000659	CcSEcCtD
Oxycodone—Malaise—Gabapentin—migraine	0.000154	0.000658	CcSEcCtD
Oxycodone—Tinnitus—Topiramate—migraine	0.000154	0.000657	CcSEcCtD
Oxycodone—Vertigo—Gabapentin—migraine	0.000154	0.000656	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Valproic Acid—migraine	0.000153	0.000654	CcSEcCtD
Oxycodone—Flushing—Topiramate—migraine	0.000153	0.000654	CcSEcCtD
Oxycodone—Cardiac disorder—Topiramate—migraine	0.000153	0.000654	CcSEcCtD
Oxycodone—Syncope—Gabapentin—migraine	0.000153	0.000654	CcSEcCtD
Oxycodone—Nausea—Propranolol—migraine	0.000153	0.000654	CcSEcCtD
Oxycodone—Leukopenia—Gabapentin—migraine	0.000153	0.000653	CcSEcCtD
Oxycodone—Dry mouth—Timolol—migraine	0.000153	0.000652	CcSEcCtD
Oxycodone—Insomnia—Valproic Acid—migraine	0.000152	0.00065	CcSEcCtD
Oxycodone—Paraesthesia—Valproic Acid—migraine	0.000151	0.000645	CcSEcCtD
Oxycodone—Palpitations—Gabapentin—migraine	0.000151	0.000645	CcSEcCtD
Oxycodone—Confusional state—Timolol—migraine	0.000151	0.000645	CcSEcCtD
Oxycodone—Vomiting—Verapamil—migraine	0.000151	0.000644	CcSEcCtD
Oxycodone—OPRM1—GPCR ligand binding—RAMP1—migraine	0.000151	0.00754	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—CALCRL—migraine	0.000151	0.00754	CbGpPWpGaD
Oxycodone—Loss of consciousness—Gabapentin—migraine	0.00015	0.000641	CcSEcCtD
Oxycodone—Dyspnoea—Valproic Acid—migraine	0.00015	0.00064	CcSEcCtD
Oxycodone—Angiopathy—Topiramate—migraine	0.00015	0.00064	CcSEcCtD
Oxycodone—Oedema—Timolol—migraine	0.00015	0.000639	CcSEcCtD
Oxycodone—Anaphylactic shock—Timolol—migraine	0.00015	0.000639	CcSEcCtD
Oxycodone—Rash—Verapamil—migraine	0.00015	0.000639	CcSEcCtD
Oxycodone—Somnolence—Valproic Acid—migraine	0.00015	0.000639	CcSEcCtD
Oxycodone—Dermatitis—Verapamil—migraine	0.00015	0.000638	CcSEcCtD
Oxycodone—Immune system disorder—Topiramate—migraine	0.000149	0.000637	CcSEcCtD
Oxycodone—Cough—Gabapentin—migraine	0.000149	0.000637	CcSEcCtD
Oxycodone—Mediastinal disorder—Topiramate—migraine	0.000149	0.000635	CcSEcCtD
Oxycodone—Infection—Timolol—migraine	0.000149	0.000635	CcSEcCtD
Oxycodone—Headache—Verapamil—migraine	0.000149	0.000635	CcSEcCtD
Oxycodone—Chills—Topiramate—migraine	0.000148	0.000633	CcSEcCtD
Oxycodone—Dyspepsia—Valproic Acid—migraine	0.000148	0.000632	CcSEcCtD
Oxycodone—Convulsion—Gabapentin—migraine	0.000148	0.000632	CcSEcCtD
Oxycodone—OPRD1—G alpha (i) signalling events—HTR1B—migraine	0.000148	0.00739	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—HTR1D—migraine	0.000148	0.00739	CbGpPWpGaD
Oxycodone—Shock—Timolol—migraine	0.000148	0.000629	CcSEcCtD
Oxycodone—Nervous system disorder—Timolol—migraine	0.000147	0.000627	CcSEcCtD
Oxycodone—Decreased appetite—Valproic Acid—migraine	0.000146	0.000624	CcSEcCtD
Oxycodone—OPRK1—Peptide ligand-binding receptors—TAC1—migraine	0.000146	0.00729	CbGpPWpGaD
Oxycodone—OPRK1—Peptide ligand-binding receptors—NPS—migraine	0.000146	0.00729	CbGpPWpGaD
Oxycodone—Arthralgia—Gabapentin—migraine	0.000146	0.000621	CcSEcCtD
Oxycodone—Myalgia—Gabapentin—migraine	0.000146	0.000621	CcSEcCtD
Oxycodone—Chest pain—Gabapentin—migraine	0.000146	0.000621	CcSEcCtD
Oxycodone—Skin disorder—Timolol—migraine	0.000146	0.000621	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Valproic Acid—migraine	0.000145	0.00062	CcSEcCtD
Oxycodone—Fatigue—Valproic Acid—migraine	0.000145	0.000619	CcSEcCtD
Oxycodone—Anxiety—Gabapentin—migraine	0.000145	0.000619	CcSEcCtD
Oxycodone—Hyperhidrosis—Timolol—migraine	0.000145	0.000618	CcSEcCtD
Oxycodone—Mental disorder—Topiramate—migraine	0.000145	0.000618	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000145	0.000617	CcSEcCtD
Oxycodone—Constipation—Valproic Acid—migraine	0.000144	0.000614	CcSEcCtD
Oxycodone—Pain—Valproic Acid—migraine	0.000144	0.000614	CcSEcCtD
Oxycodone—Malnutrition—Topiramate—migraine	0.000144	0.000614	CcSEcCtD
Oxycodone—Discomfort—Gabapentin—migraine	0.000144	0.000614	CcSEcCtD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000144	0.00719	CbGpPWpGaD
Oxycodone—Anorexia—Timolol—migraine	0.000143	0.00061	CcSEcCtD
Oxycodone—Dry mouth—Gabapentin—migraine	0.000142	0.000607	CcSEcCtD
Oxycodone—OPRD1—G alpha (i) signalling events—HTR1A—migraine	0.000142	0.00712	CbGpPWpGaD
Oxycodone—Flatulence—Topiramate—migraine	0.000142	0.000605	CcSEcCtD
Oxycodone—Tension—Topiramate—migraine	0.000141	0.000602	CcSEcCtD
Oxycodone—Nausea—Verapamil—migraine	0.000141	0.000602	CcSEcCtD
Oxycodone—Dysgeusia—Topiramate—migraine	0.000141	0.000601	CcSEcCtD
Oxycodone—Confusional state—Gabapentin—migraine	0.000141	0.0006	CcSEcCtD
Oxycodone—Hypotension—Timolol—migraine	0.00014	0.000597	CcSEcCtD
Oxycodone—Nervousness—Topiramate—migraine	0.00014	0.000596	CcSEcCtD
Oxycodone—Oedema—Gabapentin—migraine	0.00014	0.000595	CcSEcCtD
Oxycodone—Anaphylactic shock—Gabapentin—migraine	0.00014	0.000595	CcSEcCtD
Oxycodone—Back pain—Topiramate—migraine	0.000139	0.000594	CcSEcCtD
Oxycodone—OPRK1—Peptide ligand-binding receptors—EDNRA—migraine	0.000139	0.00695	CbGpPWpGaD
Oxycodone—Feeling abnormal—Valproic Acid—migraine	0.000139	0.000592	CcSEcCtD
Oxycodone—Infection—Gabapentin—migraine	0.000139	0.000592	CcSEcCtD
Oxycodone—Muscle spasms—Topiramate—migraine	0.000138	0.00059	CcSEcCtD
Oxycodone—Gastrointestinal pain—Valproic Acid—migraine	0.000138	0.000587	CcSEcCtD
Oxycodone—OPRD1—GPCR ligand binding—HTR2B—migraine	0.000137	0.00687	CbGpPWpGaD
Oxycodone—Shock—Gabapentin—migraine	0.000137	0.000586	CcSEcCtD
Oxycodone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000137	0.00686	CbGpPWpGaD
Oxycodone—Nervous system disorder—Gabapentin—migraine	0.000137	0.000584	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Timolol—migraine	0.000137	0.000583	CcSEcCtD
Oxycodone—Tachycardia—Gabapentin—migraine	0.000136	0.000581	CcSEcCtD
Oxycodone—Skin disorder—Gabapentin—migraine	0.000136	0.000578	CcSEcCtD
Oxycodone—Insomnia—Timolol—migraine	0.000136	0.000578	CcSEcCtD
Oxycodone—Hyperhidrosis—Gabapentin—migraine	0.000135	0.000576	CcSEcCtD
Oxycodone—Tremor—Topiramate—migraine	0.000135	0.000575	CcSEcCtD
Oxycodone—Paraesthesia—Timolol—migraine	0.000135	0.000574	CcSEcCtD
Oxycodone—Urticaria—Valproic Acid—migraine	0.000134	0.000571	CcSEcCtD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000134	0.00669	CbGpPWpGaD
Oxycodone—Dyspnoea—Timolol—migraine	0.000134	0.00057	CcSEcCtD
Oxycodone—Ill-defined disorder—Topiramate—migraine	0.000134	0.00057	CcSEcCtD
Oxycodone—Somnolence—Timolol—migraine	0.000133	0.000568	CcSEcCtD
Oxycodone—Body temperature increased—Valproic Acid—migraine	0.000133	0.000568	CcSEcCtD
Oxycodone—Abdominal pain—Valproic Acid—migraine	0.000133	0.000568	CcSEcCtD
Oxycodone—Anorexia—Gabapentin—migraine	0.000133	0.000568	CcSEcCtD
Oxycodone—Anaemia—Topiramate—migraine	0.000133	0.000567	CcSEcCtD
Oxycodone—Agitation—Topiramate—migraine	0.000132	0.000564	CcSEcCtD
Oxycodone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000132	0.0066	CbGpPWpGaD
Oxycodone—Dyspepsia—Timolol—migraine	0.000132	0.000563	CcSEcCtD
Oxycodone—Hypotension—Gabapentin—migraine	0.00013	0.000556	CcSEcCtD
Oxycodone—Decreased appetite—Timolol—migraine	0.00013	0.000556	CcSEcCtD
Oxycodone—Malaise—Topiramate—migraine	0.00013	0.000554	CcSEcCtD
Oxycodone—OPRK1—G alpha (i) signalling events—HTR1B—migraine	0.00013	0.00648	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—HTR1D—migraine	0.00013	0.00648	CbGpPWpGaD
Oxycodone—Gastrointestinal disorder—Timolol—migraine	0.000129	0.000552	CcSEcCtD
Oxycodone—Vertigo—Topiramate—migraine	0.000129	0.000551	CcSEcCtD
Oxycodone—Fatigue—Timolol—migraine	0.000129	0.000551	CcSEcCtD
Oxycodone—Syncope—Topiramate—migraine	0.000129	0.00055	CcSEcCtD
Oxycodone—Leukopenia—Topiramate—migraine	0.000129	0.000549	CcSEcCtD
Oxycodone—Pain—Timolol—migraine	0.000128	0.000547	CcSEcCtD
Oxycodone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000128	0.00638	CbGpPWpGaD
Oxycodone—Musculoskeletal discomfort—Gabapentin—migraine	0.000127	0.000543	CcSEcCtD
Oxycodone—Palpitations—Topiramate—migraine	0.000127	0.000542	CcSEcCtD
Oxycodone—Loss of consciousness—Topiramate—migraine	0.000127	0.000539	CcSEcCtD
Oxycodone—Insomnia—Gabapentin—migraine	0.000126	0.000539	CcSEcCtD
Oxycodone—Cough—Topiramate—migraine	0.000126	0.000536	CcSEcCtD
Oxycodone—Paraesthesia—Gabapentin—migraine	0.000125	0.000535	CcSEcCtD
Oxycodone—OPRK1—G alpha (i) signalling events—HTR1A—migraine	0.000125	0.00624	CbGpPWpGaD
Oxycodone—Convulsion—Topiramate—migraine	0.000125	0.000532	CcSEcCtD
Oxycodone—Dyspnoea—Gabapentin—migraine	0.000125	0.000531	CcSEcCtD
Oxycodone—Somnolence—Gabapentin—migraine	0.000124	0.000529	CcSEcCtD
Oxycodone—OPRD1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000124	0.00621	CbGpPWpGaD
Oxycodone—Hypersensitivity—Valproic Acid—migraine	0.000124	0.000529	CcSEcCtD
Oxycodone—Feeling abnormal—Timolol—migraine	0.000124	0.000527	CcSEcCtD
Oxycodone—OPRM1—Peptide ligand-binding receptors—NPS—migraine	0.000123	0.00616	CbGpPWpGaD
Oxycodone—OPRM1—Peptide ligand-binding receptors—TAC1—migraine	0.000123	0.00616	CbGpPWpGaD
Oxycodone—Dyspepsia—Gabapentin—migraine	0.000123	0.000524	CcSEcCtD
Oxycodone—Gastrointestinal pain—Timolol—migraine	0.000123	0.000523	CcSEcCtD
Oxycodone—Chest pain—Topiramate—migraine	0.000123	0.000523	CcSEcCtD
Oxycodone—Myalgia—Topiramate—migraine	0.000123	0.000523	CcSEcCtD
Oxycodone—Arthralgia—Topiramate—migraine	0.000123	0.000523	CcSEcCtD
Oxycodone—Anxiety—Topiramate—migraine	0.000122	0.000521	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000122	0.000519	CcSEcCtD
Oxycodone—Decreased appetite—Gabapentin—migraine	0.000121	0.000518	CcSEcCtD
Oxycodone—Discomfort—Topiramate—migraine	0.000121	0.000516	CcSEcCtD
Oxycodone—Asthenia—Valproic Acid—migraine	0.000121	0.000515	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Gabapentin—migraine	0.000121	0.000514	CcSEcCtD
Oxycodone—OPRK1—GPCR ligand binding—HTR2B—migraine	0.00012	0.00602	CbGpPWpGaD
Oxycodone—Fatigue—Gabapentin—migraine	0.00012	0.000513	CcSEcCtD
Oxycodone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.00012	0.00602	CbGpPWpGaD
Oxycodone—Dry mouth—Topiramate—migraine	0.00012	0.000511	CcSEcCtD
Oxycodone—Constipation—Gabapentin—migraine	0.000119	0.000509	CcSEcCtD
Oxycodone—Pain—Gabapentin—migraine	0.000119	0.000509	CcSEcCtD
Oxycodone—Pruritus—Valproic Acid—migraine	0.000119	0.000508	CcSEcCtD
Oxycodone—Urticaria—Timolol—migraine	0.000119	0.000508	CcSEcCtD
Oxycodone—Abdominal pain—Timolol—migraine	0.000119	0.000505	CcSEcCtD
Oxycodone—Body temperature increased—Timolol—migraine	0.000119	0.000505	CcSEcCtD
Oxycodone—Confusional state—Topiramate—migraine	0.000118	0.000505	CcSEcCtD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000118	0.00588	CbGpPWpGaD
Oxycodone—OPRM1—Peptide ligand-binding receptors—EDNRA—migraine	0.000118	0.00587	CbGpPWpGaD
Oxycodone—Oedema—Topiramate—migraine	0.000117	0.000501	CcSEcCtD
Oxycodone—Infection—Topiramate—migraine	0.000117	0.000498	CcSEcCtD
Oxycodone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000116	0.00579	CbGpPWpGaD
Oxycodone—Shock—Topiramate—migraine	0.000116	0.000493	CcSEcCtD
Oxycodone—Diarrhoea—Valproic Acid—migraine	0.000115	0.000491	CcSEcCtD
Oxycodone—Nervous system disorder—Topiramate—migraine	0.000115	0.000491	CcSEcCtD
Oxycodone—Feeling abnormal—Gabapentin—migraine	0.000115	0.000491	CcSEcCtD
Oxycodone—OPRD1—GPCR downstream signaling—RAMP1—migraine	0.000115	0.00575	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—CALCRL—migraine	0.000115	0.00575	CbGpPWpGaD
Oxycodone—Tachycardia—Topiramate—migraine	0.000115	0.000489	CcSEcCtD
Oxycodone—Gastrointestinal pain—Gabapentin—migraine	0.000114	0.000487	CcSEcCtD
Oxycodone—Skin disorder—Topiramate—migraine	0.000114	0.000487	CcSEcCtD
Oxycodone—Hyperhidrosis—Topiramate—migraine	0.000114	0.000484	CcSEcCtD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000113	0.00566	CbGpPWpGaD
Oxycodone—Anorexia—Topiramate—migraine	0.000112	0.000478	CcSEcCtD
Oxycodone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000112	0.00559	CbGpPWpGaD
Oxycodone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000112	0.00559	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000111	0.00557	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000111	0.00557	CbGpPWpGaD
Oxycodone—Dizziness—Valproic Acid—migraine	0.000111	0.000475	CcSEcCtD
Oxycodone—Urticaria—Gabapentin—migraine	0.000111	0.000473	CcSEcCtD
Oxycodone—Hypersensitivity—Timolol—migraine	0.00011	0.000471	CcSEcCtD
Oxycodone—Body temperature increased—Gabapentin—migraine	0.00011	0.000471	CcSEcCtD
Oxycodone—Abdominal pain—Gabapentin—migraine	0.00011	0.000471	CcSEcCtD
Oxycodone—Hypotension—Topiramate—migraine	0.00011	0.000468	CcSEcCtD
Oxycodone—OPRM1—G alpha (i) signalling events—HTR1B—migraine	0.00011	0.00548	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—HTR1D—migraine	0.00011	0.00548	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000109	0.00547	CbGpPWpGaD
Oxycodone—OPRK1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000109	0.00544	CbGpPWpGaD
Oxycodone—OPRM1—TCR Signaling Pathway—FOS—migraine	0.000108	0.00539	CbGpPWpGaD
Oxycodone—Asthenia—Timolol—migraine	0.000108	0.000459	CcSEcCtD
Oxycodone—Vomiting—Valproic Acid—migraine	0.000107	0.000457	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Topiramate—migraine	0.000107	0.000456	CcSEcCtD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000106	0.00532	CbGpPWpGaD
Oxycodone—Insomnia—Topiramate—migraine	0.000106	0.000453	CcSEcCtD
Oxycodone—Rash—Valproic Acid—migraine	0.000106	0.000453	CcSEcCtD
Oxycodone—Dermatitis—Valproic Acid—migraine	0.000106	0.000452	CcSEcCtD
Oxycodone—Pruritus—Timolol—migraine	0.000106	0.000452	CcSEcCtD
Oxycodone—Headache—Valproic Acid—migraine	0.000106	0.00045	CcSEcCtD
Oxycodone—OPRM1—G alpha (i) signalling events—HTR1A—migraine	0.000106	0.00527	CbGpPWpGaD
Oxycodone—Paraesthesia—Topiramate—migraine	0.000106	0.00045	CcSEcCtD
Oxycodone—Dyspnoea—Topiramate—migraine	0.000105	0.000447	CcSEcCtD
Oxycodone—Somnolence—Topiramate—migraine	0.000104	0.000445	CcSEcCtD
Oxycodone—OPRD1—Signaling by GPCR—RAMP1—migraine	0.000104	0.00522	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CALCRL—migraine	0.000104	0.00522	CbGpPWpGaD
Oxycodone—Dyspepsia—Topiramate—migraine	0.000103	0.000441	CcSEcCtD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000103	0.00515	CbGpPWpGaD
Oxycodone—Hypersensitivity—Gabapentin—migraine	0.000103	0.000439	CcSEcCtD
Oxycodone—Diarrhoea—Timolol—migraine	0.000103	0.000437	CcSEcCtD
Oxycodone—Decreased appetite—Topiramate—migraine	0.000102	0.000435	CcSEcCtD
Oxycodone—OPRM1—GPCR ligand binding—HTR2B—migraine	0.000102	0.00509	CbGpPWpGaD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000102	0.00509	CbGpPWpGaD
Oxycodone—Gastrointestinal disorder—Topiramate—migraine	0.000101	0.000432	CcSEcCtD
Oxycodone—Fatigue—Topiramate—migraine	0.000101	0.000432	CcSEcCtD
Oxycodone—OPRK1—GPCR downstream signaling—RAMP1—migraine	0.000101	0.00504	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—CALCRL—migraine	0.000101	0.00504	CbGpPWpGaD
Oxycodone—Constipation—Topiramate—migraine	0.0001	0.000428	CcSEcCtD
Oxycodone—Pain—Topiramate—migraine	0.0001	0.000428	CcSEcCtD
Oxycodone—Asthenia—Gabapentin—migraine	0.0001	0.000427	CcSEcCtD
Oxycodone—Nausea—Valproic Acid—migraine	0.0001	0.000427	CcSEcCtD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	9.93e-05	0.00496	CbGpPWpGaD
Oxycodone—Dizziness—Timolol—migraine	9.92e-05	0.000423	CcSEcCtD
Oxycodone—Pruritus—Gabapentin—migraine	9.88e-05	0.000421	CcSEcCtD
Oxycodone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	9.8e-05	0.0049	CbGpPWpGaD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	9.79e-05	0.00489	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	9.78e-05	0.00489	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	9.78e-05	0.00489	CbGpPWpGaD
Oxycodone—Feeling abnormal—Topiramate—migraine	9.68e-05	0.000413	CcSEcCtD
Oxycodone—Gastrointestinal pain—Topiramate—migraine	9.61e-05	0.00041	CcSEcCtD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	9.59e-05	0.00479	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	9.58e-05	0.00479	CbGpPWpGaD
Oxycodone—Diarrhoea—Gabapentin—migraine	9.56e-05	0.000407	CcSEcCtD
Oxycodone—Vomiting—Timolol—migraine	9.54e-05	0.000407	CcSEcCtD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	9.46e-05	0.00473	CbGpPWpGaD
Oxycodone—Rash—Timolol—migraine	9.46e-05	0.000403	CcSEcCtD
Oxycodone—Dermatitis—Timolol—migraine	9.45e-05	0.000403	CcSEcCtD
Oxycodone—Headache—Timolol—migraine	9.39e-05	0.000401	CcSEcCtD
Oxycodone—Urticaria—Topiramate—migraine	9.33e-05	0.000398	CcSEcCtD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	9.33e-05	0.00466	CbGpPWpGaD
Oxycodone—Body temperature increased—Topiramate—migraine	9.29e-05	0.000396	CcSEcCtD
Oxycodone—Abdominal pain—Topiramate—migraine	9.29e-05	0.000396	CcSEcCtD
Oxycodone—Dizziness—Gabapentin—migraine	9.23e-05	0.000394	CcSEcCtD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	9.2e-05	0.0046	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CALCRL—migraine	9.15e-05	0.00458	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—RAMP1—migraine	9.15e-05	0.00458	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—HTR1B—migraine	8.96e-05	0.00448	CbGpPWpGaD
Oxycodone—Nausea—Timolol—migraine	8.91e-05	0.00038	CcSEcCtD
Oxycodone—Vomiting—Gabapentin—migraine	8.88e-05	0.000379	CcSEcCtD
Oxycodone—Rash—Gabapentin—migraine	8.81e-05	0.000375	CcSEcCtD
Oxycodone—Dermatitis—Gabapentin—migraine	8.8e-05	0.000375	CcSEcCtD
Oxycodone—Headache—Gabapentin—migraine	8.75e-05	0.000373	CcSEcCtD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	8.72e-05	0.00436	CbGpPWpGaD
Oxycodone—Hypersensitivity—Topiramate—migraine	8.66e-05	0.000369	CcSEcCtD
Oxycodone—OPRD1—GPCR ligand binding—HTR1A—migraine	8.62e-05	0.00431	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—RAMP1—migraine	8.52e-05	0.00426	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CALCRL—migraine	8.52e-05	0.00426	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—NPS—migraine	8.49e-05	0.00424	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—TAC1—migraine	8.49e-05	0.00424	CbGpPWpGaD
Oxycodone—Asthenia—Topiramate—migraine	8.43e-05	0.000359	CcSEcCtD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	8.4e-05	0.0042	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	8.39e-05	0.00419	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—HTR1D—migraine	8.35e-05	0.00418	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—HTR2C—migraine	8.33e-05	0.00416	CbGpPWpGaD
Oxycodone—Pruritus—Topiramate—migraine	8.31e-05	0.000354	CcSEcCtD
Oxycodone—Nausea—Gabapentin—migraine	8.3e-05	0.000354	CcSEcCtD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	8.28e-05	0.00414	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	8.26e-05	0.00413	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	8.26e-05	0.00413	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	8.1e-05	0.00405	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—EDNRA—migraine	8.1e-05	0.00405	CbGpPWpGaD
Oxycodone—Diarrhoea—Topiramate—migraine	8.04e-05	0.000343	CcSEcCtD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	7.88e-05	0.00394	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—HTR1B—migraine	7.85e-05	0.00393	CbGpPWpGaD
Oxycodone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	7.83e-05	0.00391	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—CALCA—migraine	7.8e-05	0.0039	CbGpPWpGaD
Oxycodone—Dizziness—Topiramate—migraine	7.77e-05	0.000331	CcSEcCtD
Oxycodone—OPRD1—GPCR downstream signaling—HTR2B—migraine	7.77e-05	0.00388	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—RAMP1—migraine	7.74e-05	0.00387	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CALCRL—migraine	7.74e-05	0.00387	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—HTR1D—migraine	7.59e-05	0.00379	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—HTR1A—migraine	7.56e-05	0.00378	CbGpPWpGaD
Oxycodone—Vomiting—Topiramate—migraine	7.47e-05	0.000319	CcSEcCtD
Oxycodone—OPRK1—GPCR ligand binding—NPS—migraine	7.44e-05	0.00372	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—TAC1—migraine	7.44e-05	0.00372	CbGpPWpGaD
Oxycodone—Rash—Topiramate—migraine	7.41e-05	0.000316	CcSEcCtD
Oxycodone—Dermatitis—Topiramate—migraine	7.4e-05	0.000316	CcSEcCtD
Oxycodone—Headache—Topiramate—migraine	7.36e-05	0.000314	CcSEcCtD
Oxycodone—OPRK1—GPCR downstream signaling—HTR1D—migraine	7.32e-05	0.00366	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—HTR2C—migraine	7.3e-05	0.00365	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—HTR7—migraine	7.29e-05	0.00365	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—EDNRA—migraine	7.1e-05	0.00355	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	7.1e-05	0.00355	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—HTR2B—migraine	7.05e-05	0.00353	CbGpPWpGaD
Oxycodone—Nausea—Topiramate—migraine	6.98e-05	0.000298	CcSEcCtD
Oxycodone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	6.86e-05	0.00343	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—CALCA—migraine	6.84e-05	0.00342	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—HTR2B—migraine	6.81e-05	0.0034	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	6.71e-05	0.00335	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—HTR1D—migraine	6.65e-05	0.00333	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—HTR1B—migraine	6.64e-05	0.00332	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—HTR7—migraine	6.39e-05	0.0032	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—HTR1A—migraine	6.39e-05	0.00319	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—TAC1—migraine	6.29e-05	0.00315	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—NPS—migraine	6.29e-05	0.00315	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—HTR1D—migraine	6.19e-05	0.00309	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—HTR2B—migraine	6.18e-05	0.00309	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—HTR2C—migraine	6.17e-05	0.00308	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—RAMP1—migraine	6.17e-05	0.00308	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CALCRL—migraine	6.17e-05	0.00308	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—EDNRA—migraine	6e-05	0.003	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	5.88e-05	0.00294	CbGpPWpGaD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	5.8e-05	0.0029	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—CALCA—migraine	5.78e-05	0.00289	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—HTR2B—migraine	5.75e-05	0.00288	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—HTR1D—migraine	5.62e-05	0.00281	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—RAMP1—migraine	5.41e-05	0.0027	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CALCRL—migraine	5.41e-05	0.0027	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—HTR7—migraine	5.4e-05	0.0027	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—HTR2B—migraine	5.23e-05	0.00261	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—HTR2A—migraine	5.11e-05	0.00255	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—HTR1B—migraine	5.06e-05	0.00253	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.97e-05	0.00248	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—HTR1A—migraine	4.87e-05	0.00244	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—NPS—migraine	4.8e-05	0.0024	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—TAC1—migraine	4.8e-05	0.0024	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—HTR2C—migraine	4.7e-05	0.00235	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—HTR1B—migraine	4.6e-05	0.0023	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—EDNRA—migraine	4.58e-05	0.00229	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—RAMP1—migraine	4.57e-05	0.00228	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CALCRL—migraine	4.57e-05	0.00228	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HTR1D—migraine	4.48e-05	0.00224	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—HTR2A—migraine	4.48e-05	0.00224	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—HTR1B—migraine	4.44e-05	0.00222	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—HTR1A—migraine	4.42e-05	0.00221	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—CALCA—migraine	4.41e-05	0.0022	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—TAC1—migraine	4.36e-05	0.00218	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—NPS—migraine	4.36e-05	0.00218	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—HTR2C—migraine	4.27e-05	0.00214	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—HTR1A—migraine	4.27e-05	0.00214	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—TAC1—migraine	4.21e-05	0.0021	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—NPS—migraine	4.21e-05	0.0021	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HTR2B—migraine	4.17e-05	0.00208	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—EDNRA—migraine	4.16e-05	0.00208	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—HTR2C—migraine	4.13e-05	0.00206	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—HTR7—migraine	4.12e-05	0.00206	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—HTR1B—migraine	4.03e-05	0.00201	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—EDNRA—migraine	4.01e-05	0.00201	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CALCA—migraine	4e-05	0.002	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HTR1D—migraine	3.93e-05	0.00196	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—HTR1A—migraine	3.88e-05	0.00194	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—CALCA—migraine	3.86e-05	0.00193	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—TAC1—migraine	3.82e-05	0.00191	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—NPS—migraine	3.82e-05	0.00191	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—HTR2A—migraine	3.78e-05	0.00189	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—HTR1B—migraine	3.75e-05	0.00187	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—HTR2C—migraine	3.75e-05	0.00187	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—HTR7—migraine	3.74e-05	0.00187	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—LRP1—migraine	3.67e-05	0.00183	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HTR2B—migraine	3.65e-05	0.00183	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—EDNRA—migraine	3.64e-05	0.00182	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—HTR7—migraine	3.61e-05	0.00181	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—HTR1A—migraine	3.61e-05	0.0018	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CACNA1A—migraine	3.56e-05	0.00178	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—NPS—migraine	3.56e-05	0.00178	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—TAC1—migraine	3.56e-05	0.00178	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CALCA—migraine	3.51e-05	0.00175	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—HTR2C—migraine	3.49e-05	0.00174	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—HTR1B—migraine	3.41e-05	0.0017	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—EDNRA—migraine	3.39e-05	0.0017	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HTR1D—migraine	3.32e-05	0.00166	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—HTR7—migraine	3.28e-05	0.00164	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—HTR1A—migraine	3.28e-05	0.00164	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CALCA—migraine	3.26e-05	0.00163	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—TAC1—migraine	3.23e-05	0.00161	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—NPS—migraine	3.23e-05	0.00161	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—LRP1—migraine	3.22e-05	0.00161	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—HTR2C—migraine	3.17e-05	0.00158	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HTR2B—migraine	3.09e-05	0.00154	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—EDNRA—migraine	3.08e-05	0.00154	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—HTR7—migraine	3.05e-05	0.00153	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CALCA—migraine	2.96e-05	0.00148	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—HTR2A—migraine	2.89e-05	0.00144	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NOTCH4—migraine	2.81e-05	0.00141	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—HTR7—migraine	2.77e-05	0.00139	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—LRP1—migraine	2.72e-05	0.00136	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HTR1B—migraine	2.71e-05	0.00136	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—HTR2A—migraine	2.62e-05	0.00131	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HTR1A—migraine	2.61e-05	0.00131	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CACNA1A—migraine	2.58e-05	0.00129	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TAC1—migraine	2.57e-05	0.00129	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NPS—migraine	2.57e-05	0.00129	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PGR—migraine	2.57e-05	0.00129	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—HTR2A—migraine	2.53e-05	0.00127	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HTR2C—migraine	2.52e-05	0.00126	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NOTCH4—migraine	2.47e-05	0.00123	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—EDNRA—migraine	2.46e-05	0.00123	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NOTCH3—migraine	2.39e-05	0.0012	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HTR1B—migraine	2.38e-05	0.00119	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CALCA—migraine	2.36e-05	0.00118	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—HTR2A—migraine	2.3e-05	0.00115	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HTR1A—migraine	2.29e-05	0.00115	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PGR—migraine	2.26e-05	0.00113	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TAC1—migraine	2.26e-05	0.00113	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NPS—migraine	2.26e-05	0.00113	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HTR2C—migraine	2.21e-05	0.00111	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HTR7—migraine	2.21e-05	0.00111	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—EDNRA—migraine	2.15e-05	0.00108	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—HTR2A—migraine	2.14e-05	0.00107	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NOTCH3—migraine	2.1e-05	0.00105	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NOTCH4—migraine	2.09e-05	0.00104	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CALCA—migraine	2.07e-05	0.00104	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HTR1B—migraine	2.01e-05	0.00101	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—HTR2A—migraine	1.94e-05	0.000971	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HTR7—migraine	1.94e-05	0.000969	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HTR1A—migraine	1.94e-05	0.000968	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TAC1—migraine	1.91e-05	0.000953	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NPS—migraine	1.91e-05	0.000953	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PGR—migraine	1.91e-05	0.000953	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TGFBR2—migraine	1.9e-05	0.000952	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HTR2C—migraine	1.87e-05	0.000935	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CACNA1A—migraine	1.83e-05	0.000915	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—EDNRA—migraine	1.82e-05	0.00091	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NOTCH3—migraine	1.77e-05	0.000886	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CALCA—migraine	1.75e-05	0.000876	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TGFBR2—migraine	1.67e-05	0.000834	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HTR7—migraine	1.64e-05	0.000819	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HTR2A—migraine	1.55e-05	0.000774	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TGFBR2—migraine	1.41e-05	0.000705	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—ESR1—migraine	1.37e-05	0.000687	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HTR2A—migraine	1.36e-05	0.000679	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ESR1—migraine	1.2e-05	0.000602	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CACNA1A—migraine	1.2e-05	0.000599	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—MTHFR—migraine	1.18e-05	0.000589	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HTR2A—migraine	1.15e-05	0.000574	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ESR1—migraine	1.02e-05	0.000509	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—MTHFR—migraine	8.52e-06	0.000426	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—MTHFR—migraine	6.06e-06	0.000303	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—MTHFR—migraine	3.96e-06	0.000198	CbGpPWpGaD
